Data anonymisation and data privacy for clinical trial data

Clinical trials are run by pharmaceutical companies (and elsewhere) primarily in order to demonstrate safety and efficacy of new drugs and/or treatment regimes. Sharing such data for research use by third parties is regarded as good scientific practice as it allows meta-analysis, replication studies and so forth. It also promotes transparency; and indeed pharmaceutical companies … Continue reading Data anonymisation and data privacy for clinical trial data